Resultados de la búsqueda 151-160 of 13445 for enzyme papain

  1. Mayo Clinic Cardiovascular Physician Update - August 2024

    Page 1.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  4. Mayo Clinic Cardiovascular Physician Update - September 2024

    Page 1.

  5. Mayo Clinic Cardiovascular Physician Update - October 2024

    Page 1.

  6. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Cáncer de próstata - Médicos y departamentos - Mayo Clinic

    707 4.293 8 8.9 ">Diag.707 43586 12.293 4.293 13.707 5.707 8 11.414z">&quodb0EAmp.707 4.293 8 8.586 12.293 4.293 lass="aem-GridColumn aem7"-iiiogo,umn aem- ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Inotuzumab Ozogamicin and ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...